Literature DB >> 20204757

Vaccination against varicella: what's the point?

Anne A Gershon1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204757      PMCID: PMC5391037          DOI: 10.1007/978-1-4419-0981-7_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  22 in total

1.  Varicella vaccine: the crossroads is where we are not!

Authors:  P A Brunell
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

2.  Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.

Authors:  Henry Shinefield; Steve Black; Marci Thear; Daniel Coury; Keith Reisinger; Edward Rothstein; Jin Xu; Jonathan Hartzel; Barbara Evans; Laura Digilio; Florian Schödel; Michelle L Hoffman Brown; Barbara Kuter
Journal:  Pediatr Infect Dis J       Date:  2006-04       Impact factor: 2.129

3.  Commentary: protection against varicella.

Authors:  P A Brunell
Journal:  Pediatrics       Date:  1977-01       Impact factor: 7.124

4.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

Review 5.  Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine.

Authors:  P R Krause; D M Klinman
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406

6.  A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal.

Authors:  P Aaby; B Samb; F Simondon; K Knudsen; A M Seck; J Bennett; L Markowitz; H Whittle
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 May-Jun       Impact factor: 2.184

7.  Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster.

Authors:  Jason J Chen; Zhenglun Zhu; Anne A Gershon; Michael D Gershon
Journal:  Cell       Date:  2004-12-29       Impact factor: 41.582

8.  Monitoring virus strain variation following infection with VZV: is there a need and what are the implications of introducing the Oka vaccine?

Authors:  J Breuer
Journal:  Commun Dis Public Health       Date:  2003-04

9.  Effectiveness over time of varicella vaccine.

Authors:  Marietta Vázquez; Philip S LaRussa; Anne A Gershon; Linda M Niccolai; Catherine E Muehlenbein; Sharon P Steinberg; Eugene D Shapiro
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

10.  Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

Authors:  Barbara Kuter; Holly Matthews; Henry Shinefield; Steve Black; Penelope Dennehy; Barbara Watson; Keith Reisinger; Lee Lian Kim; Lisa Lupinacci; Jonathan Hartzel; Ivan Chan
Journal:  Pediatr Infect Dis J       Date:  2004-02       Impact factor: 2.129

View more
  1 in total

1.  Widespread Use of Varicella Vaccine Does Not Reduce Immunity to Zoster of Others.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  J Infect Dis       Date:  2022-02-01       Impact factor: 7.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.